跳至主要内容
临床试验/IRCT201205131556N42
IRCT201205131556N42已完成2 期

The effect of raloxifene in postmenopausal women with chronic schizophrenia: a randomized double blind and placebo controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 46 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Female

入选标准

  • Inclusion Criteria: Postmenopausal women, Diagnosis of Schizophrenia based on DSM IV , chronic Schizophrenia( duration of the disorder>2 years), Minimum Score of 20 on Negative subscale

排除标准

  • Substance dependence( except for nicotine and cafeine), IQ <70, any other mental disorder on axis I, Any serious medical or neurological problem , receiving oral antipsychotic medications during the last week or receiving any depot antipsychotic medication during the last month, receiving ECT during the last 14 days,hepatic and renal disease , Endocrine abnormality, history of thrombosis and emboli, history of abnormal uterine bleeding, uterine or breast cancer, history of CVA, Hormone replacement therapy

研究者

相似试验